相关实验视频

Updated: Jun 4, 2025

Prehospital Thrombolysis: A Manual from Berlin

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

纤维溶解剂在急诊室的使用:一个叙事审查

Brit Long¹, William J Brady², Michael Gottlieb³

¹Department of Emergency Medicine, Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, TX, USA.

The American journal of emergency medicine

|December 19, 2024

概括

纤维解质药物是治疗急性缺血性中风,心肌梗塞和肺栓塞的关键药物,通过溶解血栓来治疗血栓. 紧急诊所医生必须了解他们的指示,适应症和剂量,以便有效地照顾患者.

科学领域:

紧急医疗紧急医疗
心脏病学心脏病学
神经学神经学

背景情况:

血栓形成导致危及生命的疾病,如急性缺血性中风 (AIS),急性心肌梗塞 (AMI) 和肺栓塞 (PE).
纤维溶解药物是这些血栓紧急情况的关键治疗方式.

研究的目的:

为紧急诊所提供有关纤维蛋白分析剂的全面概述.
专注于在急诊室 (ED) 设置中使用纤维解质药物,用于AIS,AMI和PE.

主要方法:

这项研究是一个叙事性审查.
综合了当前关于纤维溶解剂的知识及其在重症监护中的应用.

主要成果:

纤维解质药物,包括高高酶 (tPA),高高酶 (TNK) 和高高酶 (rPA),对于溶解血块和恢复血管流动至关重要.
对于AIS,AMI和PE中纤维解药的使用,存在特定的指示和时间窗口.
大型出血,特别是AIS中的脑内出血 (ICH),是主要的并发症,需要密切监测.

结论:

对于急诊医生来说,了解纤维素溶解剂的适用性,适用性和适当剂量是必不可少的.
纤维解质药物显著改善了AIS,AMI和PE患者的治疗结果.
仔细选择和监测患者至关重要,以最大限度地提高益处,并最大限度地降低与纤维解药疗法相关的风险.

关键词:

心脏病学心脏病学纤维化解是一种纤维化解.纤维素分析剂纤维素分析剂血液学血液学血液学缺血性中风是因为缺血性中风.在这里,我们可以看到MI MI MI MI.心肌梗塞的心脏病发作神经学神经学这就是PE PE PE.肺栓塞肺栓塞是一种肺栓塞.呼吸系统呼吸系统呼吸系统复苏复苏复苏复苏复苏这就是为什么我们会用声音来表达.血栓溶解是一种血栓溶解.血栓缓解药物血栓缓解药物

更多相关视频

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

相关概念视频

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Adrenergic Agonists: Therapeutic Uses

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

Flail Chest-II

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History: